Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review

References

• Lipari RN, Ahrnsbrak RD, Pemberton MR, Porter JD. Risk and Protective Factors and Estimates of Substance Use Initiation: Results from the 2016 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2017. https://www.samhsa.gov/data/sites/default/files/NSDUH-DR-FFR3-2016/NSDUH-DR-FFR3-2016.htm.
   Google Scholar
• Subramaniam GA, Stitzer MA. Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder. Drug Alcohol Depend. 2009;101(1–2):13–19.
   PubMed Web of Science ®Google Scholar
• Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008;300(17):2003–2011.
   PubMed Web of Science ®Google Scholar
• Arain M, Haque M, Johal L, et al. Maturation of the adolescent brain. Neuropsychiatr Dis Treat. 2013;9:449–461.
   PubMed Web of Science ®Google Scholar
• McNicholas L. Consensus panel chair. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treat Improv Protoc. 2004;40(04-3939):1–172.
   Google Scholar
• Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211–e20161211.
   PubMedGoogle Scholar
• Center for Behavioral Health Statistics and Quality. Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016. HHS Publication No. SMA 16-4984, NSDUH Series H-51. http://www.samhsa.gov/data/
   Google Scholar
• Miech RA, Schulenberg JE, Johnston LD, Bachman JG, O’Malley PM, Patrick ME. National Press Release, “National Adolescent Drug Trends in 2017: Findings Released.” Ann Arbor, Michigan: Monitoring the Future; 2017.
   Google Scholar
• Cerdá M, Santaella J, Marshall BDL, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167(3):605–612.e2.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Shearston JA, Dawson EW, Mateu-Gelabert P, Ompad DC. Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend. 2016;158:132–138.
   PubMed Web of Science ®Google Scholar
• Wu L-T, Blazer DG, Li T-K, Woody GE. Treatment use and barriers among adolescents with prescription opioid use disorders. Addict Behav. 2011;36(12):1233–1239.
   PubMed Web of Science ®Google Scholar
• Sharma B, Bruner A, Barnett G, Fishman M. Opioid use disorders. Child Adolesc Psychiatr Clin N Am. 2016;25(3):473–487.
   PubMed Web of Science ®Google Scholar
• Tai B, Volkow ND. Treatment for substance use disorder: opportunities and challenges under the affordable care act. Soc Work Public Health 2013;28(3–4):165–174.
   PubMed Web of Science ®Google Scholar
• Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet 2011;377(9776):1506–1513.
   PubMed Web of Science ®Google Scholar
• Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction. 2010;105(9):1669–1676.
   PubMed Web of Science ®Google Scholar
• Vo HT, Burgower R, Rozenberg I, Fishman M. Home-based delivery of XR-NTX in youth with opioid addiction. J Subst Abuse Treat. 2018;85:84–89.
   PubMed Web of Science ®Google Scholar
• Marsch LA, Bickel WK, Badger GJ, et al. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry. 2005;62(10):1157–1164.
   PubMed Web of Science ®Google Scholar
• Marsch LA, Moore SK, Borodovsky JT, et al. A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction. 2016;111(8):1406–1415.
   PubMed Web of Science ®Google Scholar
• Matson SC, Hobson G, Abdel-Rasoul M, Bonny AE. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. J Addict Med. 2014;8(3):176–182.
   PubMed Web of Science ®Google Scholar
• Boyd P, Layland WR, Crickmay JR. Treatment and follow-up of adolescents addicted to heroin. Br Med J. 1971;4(5787):604–605.
   PubMedGoogle Scholar
• Rosenberg CM, Patch VD. Methadone use in adolescent heroin addicts. JAMA. 1972;220(7):991–993.
   PubMed Web of Science ®Google Scholar
• Deangelis GG, Lehmann WX. Adolescents and short term, low dose methadone maintenance. Subst Use Misuse. 1973;8(5):853–863.
   Google Scholar
• Bell J, Mutch C. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review. Drug Alcohol Rev. 2006;25(2):167–171.
   PubMed Web of Science ®Google Scholar
• Hadland SE, Bagley SM, Rodean J, et al. Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatr. 2018;172(11):1029.
   PubMed Web of Science ®Google Scholar
• ACOG. Committee opinion 711: opioid use disorder in pregnancy. Obstet Gynecol 2017;30(2):e81–e94.
   Google Scholar
• ACOG. Committee opinion 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol 2012;119(5):1070–1076.
   PubMedGoogle Scholar
• Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–2331.
   PubMed Web of Science ®Google Scholar
• Meyer MC, Johnston AM, Crocker AM, Heil SH. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med. 2015;9(2):81–86.
   PubMed Web of Science ®Google Scholar
• Kelty E, Hulse G. A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls. Drugs. 2017;77(11):1199–1210.
   PubMed Web of Science ®Google Scholar
• Kelty E, Hulse G. A retrospective cohort study of birth outcomes in neonates exposed to naltrexone in utero: a comparison with methadone-, buprenorphine- and non-opioid-exposed neonates. Drugs 2017;77(11):1211–1219.
   PubMed Web of Science ®Google Scholar